Kymera Therapeutics, Inc.

Report date
9/30/2021
Quarter
2021 Q3
Filed
11/15/2021
Shares
65,941
Value ($000)
3,873
Weight
0.0%
2021 Q2 - 2021 Q3 (2 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).